Ara
Toplam kayıt 6, listelenen: 1-6
Systemic Onset Juvenile Idiopathic Arthritis: A Single Center Experience
(2019)
Systemic juvenile idiopathic arthritis (sJIA) presents with prolonged fever and systemic features such as arthritis, rash, lymphadenopathy, hepatosplenomegaly and serositis. In this study, we aimed to evaluate the clinical ...
Tocilizumab Treatment In Juvenile Idiopathic Arthritis Patients: A Single Center Experience
(2019)
Tocilizumab is a monoclonal antibody against interleukin-6 that has recently emerged as an alternative treatment modality for juvenile idiopathic arthritis (JIA). In the present study, we aimed to discuss the clinical and ...